Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 5
2004 3
2005 6
2006 3
2007 3
2008 4
2009 4
2010 2
2011 3
2012 3
2013 8
2014 6
2015 4
2016 8
2017 6
2018 6
2019 4
2020 6
2021 5
2022 6
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Corrigendum to Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins > Nutr Metab Cardiovasc Dis. 2022 Sep;32(9):2255-2263.
Buzzetti R, Fadini GP, Nicolucci A, Larosa M, Rossi MC, Cucinotta D; RESTORE-2 Study Group. Buzzetti R, et al. Among authors: cucinotta d. Nutr Metab Cardiovasc Dis. 2023 Apr;33(4):920-921. doi: 10.1016/j.numecd.2023.02.006. Epub 2023 Mar 21. Nutr Metab Cardiovasc Dis. 2023. PMID: 36948942 No abstract available.
Long-Term Influence of Locus of Control and Quality of Life on Metabolic Profile in Elderly Subjects with Type 2 Diabetes.
Giandalia A, Ragonese M, Alessi E, Ruffo MC, Sardella A, Cuttone A, Aragona MA, Versace AG, Basile G, Cucinotta D, Squadrito G, Russo GT. Giandalia A, et al. Among authors: cucinotta d. Int J Environ Res Public Health. 2022 Oct 17;19(20):13381. doi: 10.3390/ijerph192013381. Int J Environ Res Public Health. 2022. PMID: 36293961 Free PMC article.
Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY).
Fadini GP, Buzzetti R, Nicolucci A, Larosa M, Rossi MC, Cucinotta D; RESTORE-2 Study Group. Fadini GP, et al. Among authors: cucinotta d. Acta Diabetol. 2022 Oct;59(10):1317-1330. doi: 10.1007/s00592-022-01925-9. Epub 2022 Jul 21. Acta Diabetol. 2022. PMID: 35864262 Free PMC article.
Underestimation of hypoglycaemia using patients' diaries compared with downloaded glucometer data: an ITAS post hoc analysis.
Buzzetti R, Bonadonna RC, Giaccari A, Perseghin G, Cucinotta D, Fanelli C, Avogaro A, Aimaretti G, Larosa M, Pacchetti I, Bolli GB. Buzzetti R, et al. Among authors: cucinotta d. Diabetes Obes Metab. 2022 Feb;24(2):327-331. doi: 10.1111/dom.14560. Epub 2021 Oct 22. Diabetes Obes Metab. 2022. PMID: 34595824 Free PMC article. No abstract available.
Structured self-monitoring of blood glucose is associated with more appropriate therapeutic interventions than unstructured self-monitoring: A novel analysis of data from the PRISMA trial.
Di Molfetta S, Bosi E, Ceriello A, Cucinotta D, Tiengo A, Scavini M, Piccolo C, Bonizzoni E, Acmet E, Giorgino F; PRISMA STUDY GROUP. Di Molfetta S, et al. Among authors: cucinotta d. Diabetes Res Clin Pract. 2021 Nov;181:109070. doi: 10.1016/j.diabres.2021.109070. Epub 2021 Sep 27. Diabetes Res Clin Pract. 2021. PMID: 34592390 Free article.
89 results